XOMA Corporation – NASDAQ:XOMA
XOMA stock price today
$32.06
+5.76
+21.9%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 12 hours
XOMA stock price monthly change
-2.59%
month
XOMA stock price quarterly change
-2.59%
quarter
XOMA stock price yearly change
+40.57%
year
XOMA key metrics
Market Cap | 312.71M |
Enterprise value | 296.55M |
P/E | -10.60 |
EV/Sales | 13.72 |
EV/EBITDA | -7.22 |
Price/Sales | 14.79 |
Price/Book | 3.74 |
PEG ratio | 0.58 |
EPS | -3.44 |
Revenue | 5.81M |
EBITDA | -21.43M |
Income | -39.61M |
Revenue Q/Q | 240.96% |
Revenue Y/Y | 73.10% |
Profit margin | -138.67% |
Oper. margin | -136.09% |
Gross margin | 98.94% |
EBIT margin | -136.09% |
EBITDA margin | -368.92% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeXOMA stock price history
XOMA stock forecast
XOMA financial statements
| Jun 2023 | 1.65M | -5.4M | -325.69% |
|---|---|---|---|
| Sep 2023 | 830K | -5.50M | -663.73% |
| Dec 2023 | 1.83M | -20.10M | -1097.05% |
| Mar 2024 | 1.49M | -8.59M | -576.85% |
| 2025 | 26.93M | -15.7M | -58.29% |
|---|---|---|---|
| 2026 | 38.23M | -5.1M | -13.34% |
| 2027 | 53.8M | 4.64M | 8.64% |
| 2028 | 83.9M | 31.77M | 37.87% |
Analysts Price target
Financials & Ratios estimates
Paying a dividend while loss making.
7.94%
Yield TTM
| Payout ratio | -18.26% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | 1.49% |
| 2022 | 2.61% |
| 2023 | 2.58% |
| Jun 2023 | 125661000 | 15.53M | 12.36% |
|---|---|---|---|
| Sep 2023 | 124094000 | 18.13M | 14.61% |
| Dec 2023 | 234301000 | 145.58M | 62.13% |
| Mar 2024 | 219420000 | 137.07M | 62.47% |
| Jun 2023 | -7.20M | -4.48M | -1.16M |
|---|---|---|---|
| Sep 2023 | -2.09M | 5.49M | -1.36M |
| Dec 2023 | -3.92M | 5.51M | 124.49M |
| Mar 2024 | -5.52M | -7.24M | -4.37M |
XOMA alternative data
| Aug 2023 | 11 |
|---|---|
| Sep 2023 | 11 |
| Oct 2023 | 11 |
| Nov 2023 | 11 |
| Dec 2023 | 12 |
| Jan 2024 | 12 |
| Feb 2024 | 12 |
| Apr 2024 | 13 |
| May 2024 | 13 |
| Jun 2024 | 13 |
| Jul 2024 | 13 |
XOMA other data
19.53%
-38.18%
of XOMA is owned by hedge funds
28
-19
2.22M
-4.37M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2023 | 22249 | 0 |
| May 2023 | 9350 | 0 |
| Sep 2023 | 2500 | 0 |
| Oct 2023 | 2750 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SITKO BRADLEY officer: Chief Investment Officer | Common Stock | 250 | $13.89 | $3,473 | ||
Purchase | SITKO BRADLEY officer: Chief Investment Officer | Common Stock | 1,500 | $14.25 | $21,375 | ||
Purchase | HUGHES OWEN director, officer.. | Common Stock | 1,000 | $13.83 | $13,830 | ||
Purchase | HUGHES OWEN director, officer.. | Common Stock | 2,499 | $14.43 | $36,061 | ||
Purchase | HUGHES OWEN director, officer.. | Common Stock | 1 | $14.65 | $15 | ||
Purchase | SITKO BRADLEY officer: Chief Investment Officer | Common Stock | 1,000 | $17.2 | $17,200 | ||
Purchase | SITKO BRADLEY officer: Chief Investment Officer | Common Stock | 500 | $17 | $8,500 | ||
Purchase | HUGHES OWEN director, officer.. | Depositary Shares - 8.375% B Cumulative Stock | 1,032 | $23.79 | $24,551 | ||
Purchase | SITKO BRADLEY officer: Chief Investment Officer | Common Stock | 850 | $19 | $16,150 | ||
Purchase | HUGHES OWEN director, officer.. | Depositary Shares - 8.375% B Cumulative Stock | 200 | $23.33 | $4,666 |
| Quarter | Transcript |
|---|---|
| Q4 2016 17 Mar 2017 | Q4 2016 Earnings Call Transcript |
| Q4 2015 10 Mar 2016 | Q4 2015 Earnings Call Transcript |
| Q3 2015 6 Nov 2015 | Q3 2015 Earnings Call Transcript |
| Q2 2015 7 Aug 2015 | Q2 2015 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. James R. Neal (1956) Chief Executive Officer & Chairman | $742,560 |
| Mr. Thomas M. Burns (1974) Senior Vice President of Fin. & Chief Financial Officer | $495,380 |
-
What's the price of XOMA stock today?
One share of XOMA stock can currently be purchased for approximately $32.06.
-
When is XOMA's next earnings date?
Unfortunately, XOMA's (XOMA) next earnings date is currently unknown.
-
Does XOMA pay dividends?
Yes, XOMA pays dividends and its trailing 12-month yield is 7.95% with -18% payout ratio.It means that the company is paying a dividend while loss making. The last XOMA stock dividend of undefined was paid on 24 Sep 2025.
-
How much money does XOMA make?
XOMA has a market capitalization of 312.71M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 21.06% to 4.76M US dollars.
-
What is XOMA's stock symbol?
XOMA Corporation is traded on the NASDAQ under the ticker symbol "XOMA".
-
What is XOMA's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of XOMA?
Shares of XOMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are XOMA's key executives?
XOMA's management team includes the following people:
- Mr. James R. Neal Chief Executive Officer & Chairman(age: 69, pay: $742,560)
- Mr. Thomas M. Burns Senior Vice President of Fin. & Chief Financial Officer(age: 51, pay: $495,380)
-
How many employees does XOMA have?
As Jul 2024, XOMA employs 13 workers.
-
When XOMA went public?
XOMA Corporation is publicly traded company for more then 39 years since IPO on 6 Jun 1986.
-
What is XOMA's official website?
The official website for XOMA is xoma.com.
-
Where are XOMA's headquarters?
XOMA is headquartered at 2200 Powell Street, EmeryVille, CA.
-
How can i contact XOMA?
XOMA's mailing address is 2200 Powell Street, EmeryVille, CA and company can be reached via phone at +51 02047200.
XOMA company profile:
XOMA Corporation
xoma.comExchange:
NASDAQ
Full time employees:
13
Industry:
Biotechnology
Sector:
Healthcare
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
2200 Powell Street
EmeryVille, CA 94608
EmeryVille, CA 94608
CIK: 0000791908
ISIN: US98419J2069
CUSIP: 98419J206
